9 results on '"Chin, Bum Sik"'
Number of results to display per page
Search Results
2. Molecular epidemiology identifies HIV transmission networks associated with younger age and heterosexual exposure among Korean individuals.
- Author
-
Chin, Bum Sik, Chaillon, Antoine, Mehta, Sanjay R, Wertheim, Joel O, Kim, Gayeon, Shin, Hyoung-Shik, and Smith, Davey M
- Subjects
Humans ,HIV-1 ,HIV Infections ,RNA ,Viral ,Cluster Analysis ,Heterosexuality ,Homosexuality ,Male ,Age Factors ,Phylogeny ,Drug Resistance ,Viral ,Genotype ,Adult ,Middle Aged ,Female ,Male ,pol Gene Products ,Human Immunodeficiency Virus ,Young Adult ,Molecular Epidemiology ,Republic of Korea ,cluster analysis ,human immunodeficiency virus ,molecular epidemiology ,phylogeny ,RNA ,Viral ,Homosexuality ,Drug Resistance ,pol Gene Products ,Human Immunodeficiency Virus ,HIV/AIDS ,Genetics ,Infection ,Democratic People's Republic of Korea ,Virology ,Medical Microbiology ,Microbiology ,Artificial Intelligence and Image Processing - Abstract
To evaluate if HIV transmission networks could be elucidated from data collected in a short time frame, 131 HIV-1 pol sequences were analyzed which were generated from treatment-naïve Korean individuals who were sequentially identified over 1 year. A transmission linkage was inferred when there was a genetic distance
- Published
- 2016
3. Travel Pattern and Prescription Analysis at a Single Travel Clinic Specialized for Yellow Fever Vaccination in South Korea.
- Author
-
Chin, Bum Sik, Kim, Jae Yoon, Gianella, Sara, and Lee, Myunghee
- Subjects
Antibiotic prophylaxis ,Malaria ,Travel medicine ,Vaccine ,Yellow fever ,Vector-Borne Diseases ,Prevention ,Immunization ,Orphan Drug ,Infectious Diseases ,Rare Diseases ,Vaccine Related ,Infection ,Antibiotic prophylaxis Malaria Travel medicine Vaccine Yellow fever - Abstract
BackgroundTravel-related risks for infectious diseases vary depending on travel patterns such as purpose, destination, and duration. In this study, we describe the patterns of travel and prescription of vaccines as well as malaria prophylaxis medication (MPM) at a travel clinic in South Korea to identify the gaps to fill for the optimization of pre-travel consultation.Materials and methodsA cohort of travel clinic visitors in 2011 was constructed and early one-third of the visitors of each month were reviewed. During the study period, 10,009 visited the travel clinic and a retrospective chart review was performed for 3,332 cases for analysis of travel patterns and prescriptions.ResultsPeople receiving yellow fever vaccine (YFV) (n = 2,933) were traveling more frequently for business and tourism and less frequently for providing non-medical service or research/education compared to the 399 people who did not receive the YFV. Overall, most people were traveling to Eastern Africa, South America, and Western Africa, while South-Eastern Asia was the most common destination for the non-YFV group. Besides YFV, the typhoid vaccine was the most commonly prescribed (54.2%), while hepatitis A presented the highest coverage (74.7%) considering the natural immunity, prior and current vaccination history. Additionally, 402 (82.5%) individuals received a prescription for MPM among the 487 individuals travelling to areas with high-risk of malaria infection. Age over 55 was independently associated with receiving MPM prescription, while purpose of providing service and travel duration over 10 days were associated with no MPM prescription, despite travelling to high-risk areas.ConclusionEastern Africa and South America were common travel destinations among the visitors to a travel clinic for YFV, and most of them were travelling for tourism and business. For the individuals who are traveling to areas with high-risk for malaria, more proactive approach might be required in case of younger age travelers, longer duration, and travel purpose of providing service to minimize the risk of malaria infection.
- Published
- 2016
4. Travel Pattern and Prescription Analysis at a Single Travel Clinic Specialized for Yellow Fever Vaccination in South Korea.
- Author
-
Chin, Bum Sik, Kim, Jae Yoon, Gianella, Sara, and Lee, Myunghee
- Subjects
Antibiotic prophylaxis ,Malaria ,Travel medicine ,Vaccine ,Yellow fever ,Orphan Drug ,Vaccine Related ,Infectious Diseases ,Vector-Borne Diseases ,Prevention ,Immunization ,Rare Diseases ,Infection ,Good Health and Well Being ,Antibiotic prophylaxis Malaria Travel medicine Vaccine Yellow fever - Abstract
BackgroundTravel-related risks for infectious diseases vary depending on travel patterns such as purpose, destination, and duration. In this study, we describe the patterns of travel and prescription of vaccines as well as malaria prophylaxis medication (MPM) at a travel clinic in South Korea to identify the gaps to fill for the optimization of pre-travel consultation.Materials and methodsA cohort of travel clinic visitors in 2011 was constructed and early one-third of the visitors of each month were reviewed. During the study period, 10,009 visited the travel clinic and a retrospective chart review was performed for 3,332 cases for analysis of travel patterns and prescriptions.ResultsPeople receiving yellow fever vaccine (YFV) (n = 2,933) were traveling more frequently for business and tourism and less frequently for providing non-medical service or research/education compared to the 399 people who did not receive the YFV. Overall, most people were traveling to Eastern Africa, South America, and Western Africa, while South-Eastern Asia was the most common destination for the non-YFV group. Besides YFV, the typhoid vaccine was the most commonly prescribed (54.2%), while hepatitis A presented the highest coverage (74.7%) considering the natural immunity, prior and current vaccination history. Additionally, 402 (82.5%) individuals received a prescription for MPM among the 487 individuals travelling to areas with high-risk of malaria infection. Age over 55 was independently associated with receiving MPM prescription, while purpose of providing service and travel duration over 10 days were associated with no MPM prescription, despite travelling to high-risk areas.ConclusionEastern Africa and South America were common travel destinations among the visitors to a travel clinic for YFV, and most of them were travelling for tourism and business. For the individuals who are traveling to areas with high-risk for malaria, more proactive approach might be required in case of younger age travelers, longer duration, and travel purpose of providing service to minimize the risk of malaria infection.
- Published
- 2016
5. Travel Pattern and Prescription Analysis at a Single Travel Clinic Specialized for Yellow Fever Vaccination in South Korea
- Author
-
Chin, Bum Sik, Kim, Jae Yoon, Gianella, Sara, and Lee, Myunghee
- Subjects
Tourism ,Commercial Services ,Commerce ,Management ,Tourism and Services ,Vaccine Related ,Rare Diseases ,Infectious Diseases ,Malaria ,Immunization ,Prevention ,Emerging Infectious Diseases ,Vector-Borne Diseases ,Clinical Research ,3.4 Vaccines ,Infection ,Good Health and Well Being ,Travel medicine ,Yellow fever ,Vaccine ,Antibiotic prophylaxis ,Antibiotic prophylaxis Malaria Travel medicine Vaccine Yellow fever - Abstract
BackgroundTravel-related risks for infectious diseases vary depending on travel patterns such as purpose, destination, and duration. In this study, we describe the patterns of travel and prescription of vaccines as well as malaria prophylaxis medication (MPM) at a travel clinic in South Korea to identify the gaps to fill for the optimization of pre-travel consultation.Materials and methodsA cohort of travel clinic visitors in 2011 was constructed and early one-third of the visitors of each month were reviewed. During the study period, 10,009 visited the travel clinic and a retrospective chart review was performed for 3,332 cases for analysis of travel patterns and prescriptions.ResultsPeople receiving yellow fever vaccine (YFV) (n = 2,933) were traveling more frequently for business and tourism and less frequently for providing non-medical service or research/education compared to the 399 people who did not receive the YFV. Overall, most people were traveling to Eastern Africa, South America, and Western Africa, while South-Eastern Asia was the most common destination for the non-YFV group. Besides YFV, the typhoid vaccine was the most commonly prescribed (54.2%), while hepatitis A presented the highest coverage (74.7%) considering the natural immunity, prior and current vaccination history. Additionally, 402 (82.5%) individuals received a prescription for MPM among the 487 individuals travelling to areas with high-risk of malaria infection. Age over 55 was independently associated with receiving MPM prescription, while purpose of providing service and travel duration over 10 days were associated with no MPM prescription, despite travelling to high-risk areas.ConclusionEastern Africa and South America were common travel destinations among the visitors to a travel clinic for YFV, and most of them were travelling for tourism and business. For the individuals who are traveling to areas with high-risk for malaria, more proactive approach might be required in case of younger age travelers, longer duration, and travel purpose of providing service to minimize the risk of malaria infection.
- Published
- 2016
6. Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
- Author
-
Rhee, Soo-Yon, Blanco, Jose Luis, Jordan, Michael R, Taylor, Jonathan, Lemey, Philippe, Varghese, Vici, Hamers, Raph L, Bertagnolio, Silvia, de Wit, Tobias F Rinke, Aghokeng, Avelin F, Albert, Jan, Avi, Radko, Avila-Rios, Santiago, Bessong, Pascal O, Brooks, James I, Boucher, Charles AB, Brumme, Zabrina L, Busch, Michael P, Bussmann, Hermann, Chaix, Marie-Laure, Chin, Bum Sik, D'Aquin, Toni T, De Gascun, Cillian F, Derache, Anne, Descamps, Diane, Deshpande, Alaka K, Djoko, Cyrille F, Eshleman, Susan H, Fleury, Herve, Frange, Pierre, Fujisaki, Seiichiro, Harrigan, P Richard, Hattori, Junko, Holguin, Africa, Hunt, Gillian M, Ichimura, Hiroshi, Kaleebu, Pontiano, Katzenstein, David, Kiertiburanakul, Sasisopin, Kim, Jerome H, Kim, Sung Soon, Li, Yanpeng, Lutsar, Irja, Morris, Lynn, Ndembi, Nicaise, Kee, Peng NG, Paranjape, Ramesh S, Peeters, Martine, Poljak, Mario, Price, Matt A, Ragonnet-Cronin, Manon L, Reyes-Terán, Gustavo, Rolland, Morgane, Sirivichayakul, Sunee, Smith, Davey M, Soares, Marcelo A, Soriano, Vincent V, Ssemwanga, Deogratius, Stanojevic, Maja, Stefani, Mariane A, Sugiura, Wataru, Sungkanuparph, Somnuek, Tanuri, Amilcar, Tee, Kok Keng, Truong, Hong-Ha M, van de Vijver, David AMC, Vidal, Nicole, Yang, Chunfu, Yang, Rongge, Yebra, Gonzalo, Ioannidis, John PA, Vandamme, Anne-Mieke, and Shafer, Robert W
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Good Health and Well Being ,Medical and Health Sciences ,General & Internal Medicine ,Biomedical and clinical sciences ,Health sciences - Published
- 2015
7. Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea
- Author
-
Chin, Bum Sik, Shin, Hyoung-Shik, Kim, Gayeon, Wagner, Gabriel A, Gianella, Sara, and Smith, Davey M
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Sexually Transmitted Infections ,Infectious Diseases ,HIV/AIDS ,Antimicrobial Resistance ,Women's Health ,2.1 Biological and endogenous factors ,5.1 Pharmaceuticals ,Infection ,Good Health and Well Being ,Adult ,Alkynes ,Anti-HIV Agents ,Benzoxazines ,Cluster Analysis ,Cyclopropanes ,Drug Resistance ,Viral ,Genotype ,HIV Infections ,HIV Reverse Transcriptase ,HIV-1 ,Humans ,Incidence ,Male ,Molecular Sequence Data ,Mutation ,Missense ,Phylogeny ,Republic of Korea ,Sequence Analysis ,DNA ,Adult Anti-HIV Agents/pharmacology/*therapeutic use Benzoxazines/pharmacology/*therapeutic use Cluster Analysis *Drug Resistance ,Viral Genotype HIV Infections/epidemiology/transmission/*virology HIV Reverse Transcriptase/*genetics HIV-1/*drug effects/enzymology/genetics/isolation & purification Humans Incidence Male Molecular Sequence Data *Mutation ,Missense Phylogeny Republic of Korea/epidemiology Sequence Analysis ,DNA ,Clinical Sciences ,Virology ,Clinical sciences - Abstract
Previous studies reported a relatively low prevalence of transmitted drug resistance (TDR) in South Korea (
- Published
- 2015
8. Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea.
- Author
-
Chin, Bum Sik, Shin, Hyoung-Shik, Kim, Gayeon, Wagner, Gabriel A, Gianella, Sara, and Smith, Davey M
- Subjects
Humans ,HIV-1 ,HIV Infections ,Alkynes ,Cyclopropanes ,Benzoxazines ,Anti-HIV Agents ,Incidence ,Cluster Analysis ,Sequence Analysis ,DNA ,Phylogeny ,Drug Resistance ,Viral ,Genotype ,Mutation ,Missense ,Molecular Sequence Data ,Adult ,Male ,HIV Reverse Transcriptase ,Republic of Korea ,Infectious Diseases ,HIV/AIDS ,5.1 Pharmaceuticals ,Infection ,Adult Anti-HIV Agents/pharmacology/*therapeutic use Benzoxazines/pharmacology/*therapeutic use Cluster Analysis *Drug Resistance ,Viral Genotype HIV Infections/epidemiology/transmission/*virology HIV Reverse Transcriptase/*genetics HIV-1/*drug effects/enzymology/genetics/isolation & purification Humans Incidence Male Molecular Sequence Data *Mutation ,Missense Phylogeny Republic of Korea/epidemiology Sequence Analysis ,DNA ,Virology ,Clinical Sciences - Abstract
Previous studies reported a relatively low prevalence of transmitted drug resistance (TDR) in South Korea (
- Published
- 2015
9. Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
- Author
-
Rhee, Soo-Yon, Blanco, Jose Luis, Jordan, Michael R, Taylor, Jonathan, Lemey, Philippe, Varghese, Vici, Hamers, Raph L, Bertagnolio, Silvia, de Wit, Tobias F Rinke, Aghokeng, Avelin F, Albert, Jan, Avi, Radko, Avila-Rios, Santiago, Bessong, Pascal O, Brooks, James I, Boucher, Charles AB, Brumme, Zabrina L, Busch, Michael P, Bussmann, Hermann, Chaix, Marie-Laure, Chin, Bum Sik, D'Aquin, Toni T, De Gascun, Cillian F, Derache, Anne, Descamps, Diane, Deshpande, Alaka K, Djoko, Cyrille F, Eshleman, Susan H, Fleury, Herve, Frange, Pierre, Fujisaki, Seiichiro, Harrigan, P Richard, Hattori, Junko, Holguin, Africa, Hunt, Gillian M, Ichimura, Hiroshi, Kaleebu, Pontiano, Katzenstein, David, Kiertiburanakul, Sasisopin, Kim, Jerome H, Kim, Sung Soon, Li, Yanpeng, Lutsar, Irja, Morris, Lynn, Ndembi, Nicaise, Kee, Peng NG, Paranjape, Ramesh S, Peeters, Martine, Poljak, Mario, Price, Matt A, Ragonnet-Cronin, Manon L, Reyes-Terán, Gustavo, Rolland, Morgane, Sirivichayakul, Sunee, Smith, Davey M, Soares, Marcelo A, Soriano, Vincent V, Ssemwanga, Deogratius, Stanojevic, Maja, Stefani, Mariane A, Sugiura, Wataru, Sungkanuparph, Somnuek, Tanuri, Amilcar, Tee, Kok Keng, Truong, Hong-Ha M, van de Vijver, David AMC, Vidal, Nicole, Yang, Chunfu, Yang, Rongge, Yebra, Gonzalo, Ioannidis, John PA, Vandamme, Anne-Mieke, and Shafer, Robert W
- Subjects
Medical and Health Sciences ,General & Internal Medicine - Published
- 2015
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.